Triple-negative breast cancer: IHC biomarker classification clearly delineates triple-negative breast cancer, identified by the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) proteins [146]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.